Literature DB >> 3486936

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

C A Dinarello, J G Cannon, S M Wolff, H A Bernheim, B Beutler, A Cerami, I S Figari, M A Palladino, J V O'Connor.   

Abstract

Recombinant human tumor necrosis factor (rTNF alpha) injected intravenously into rabbits produces a rapid-onset, monophasic fever indistinguishable from the fever produced by rIL-1. On a weight basis (1 microgram/kg) rTNF alpha and rIL-1 produce the same amount of fever and induce comparable levels of PGE2 in rabbit hypothalamic cells in vitro; like IL-1, TNF fever is blocked by drugs that inhibit cyclooxygenase. At higher doses (10 micrograms/kg) rTNF alpha produces biphasic fevers. The first fever reaches peak elevation 45-55 min after bolus injection and likely represents a direct action on the thermoregulatory center. During the second fever peak (3 h later), a circulating endogenous pyrogen can be shown present using passive transfer of plasma into fresh rabbits. This likely represents the in vivo induction of IL-1. In vitro, rTNF alpha induces the release of IL-1 activity from human mononuclear cells with maximal production observed at 50-100 ng/ml of rTNF alpha. In addition, rTNF alpha and rIFN-gamma have a synergistic effect on IL-1 production. The biological activity of rTNF alpha could be distinguished from IL-1 in three ways: the monophasic pyrogenic activity of rIL-1 was destroyed at 70 degrees C, whereas rTNF alpha remained active; anti-IL-1 neutralized IL-1 but did recognize rTNF alpha or natural cachectin nor neutralize its cytotoxic effect; and unlike IL-1, rTNF alpha was not active in the mitogen-stimulated T cell proliferation assay. The possibility that endotoxin was responsible for rTNF alpha fever and/or the induction of IL-1 was ruled-out in several studies: rTNF alpha produced fever in the endotoxin-resistant C3H/HeJ mice; the IL-1-inducing property of rTNF alpha was destroyed either by heat (70 degrees C) or trypsinization, and was unaffected by polymyxin B; pyrogenic tolerance to daily injections of rTNF alpha did not occur; levels of endotoxin, as determined in the Limulus amebocyte lysate, were below the minimum rabbit pyrogen dose; and these levels of endotoxin were confirmed by gas chromatography/mass spectrometry analysis for the presence of beta-hydroxymyristic acid. Although rTNF alpha is not active in T cell proliferation assays, it may mimic IL-1 in a T cell assay, since high concentrations of rTNF alpha induced IL-1 from epithelial or macrophagic cells in the thymocyte preparations. These studies show that TNF (cachectin) is another endogenous pyrogen which, like IL-1 and IFN-alpha, directly stimulate hypothalamic PGE2 synthesis. In addition, rTNF alpha is an endogenous inducer of IL-1.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486936      PMCID: PMC2188124          DOI: 10.1084/jem.163.6.1433

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  47 in total

1.  Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation.

Authors:  L J Rosenwasser; C A Dinarello
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

2.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

3.  Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cat.

Authors:  F Coceani; I Bishai; C A Dinarello; F A Fitzpatrick
Journal:  Am J Physiol       Date:  1983-06

4.  Human leukocytic pyrogen induces release of specific granule contents from human neutrophils.

Authors:  M S Klempner; C A Dinarello; J I Gallin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

Review 5.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

6.  Resin-coated 5-aminosalicylic acid (Asacol) in rheumatoid arthritis.

Authors:  R D Situnayake; B McConkey
Journal:  Br J Rheumatol       Date:  1985-05

7.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

8.  Studies on the pathogenesis of fever with influenzal viruses. I. The appearance of an endogenous pyrogen in the blood following intravenous injection of virus.

Authors:  E ATKINS; W C HUANG
Journal:  J Exp Med       Date:  1958-03-01       Impact factor: 14.307

9.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

10.  Release of endogenous pyrogen-activating factor from concanavalin A-stimulated human lymphocytes.

Authors:  H A Bernheim; L H Block; L Francis; E Atkins
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  363 in total

1.  Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis.

Authors:  R Hussain; H Shiratsuchi; M Phillips; J Ellner; R S Wallis
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment.

Authors:  J Fang; Y Wang; J M Krueger
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  MRP 8/14 as marker for Plasmodium falciparum-induced malaria episodes in individuals in a holoendemic area.

Authors:  G Bordmann; G Burmeister; S Saladin; H Urassa; S Mwankyusye; N Weiss; M Tanner
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products.

Authors:  C D Kelly; C M Russo; B Y Rubin; H W Murray
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

5.  Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

Authors:  G Buchan; K Barrett; M Turner; D Chantry; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

6.  Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Authors:  S N Vogel; E N Kaufman; M D Tate; R Neta
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

Authors:  J W Mier; G Vachino; J W van der Meer; R P Numerof; S Adams; J G Cannon; H A Bernheim; M B Atkins; D R Parkinson; C A Dinarello
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

8.  Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta.

Authors:  S E Goldblum; K Yoneda; D A Cohen; C J McClain
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

9.  Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Authors:  H Repo; M Jäättelä; M Leirisalo-Repo; M Hurme
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Tumour necrosis factor in synovial exudates.

Authors:  F S Di Giovine; G Nuki; G W Duff
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.